Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Myriad Genetics and National Cancer Center Hospital East in Japan Partner on Pan-Cancer MRD Monitoring Clinical Trial: SCRUM-MONSTAR-SCREEN-3

Wednesday, February 28, 2024

Myriad Genetics Inc a leading company in genetic testing and precision medicine has announced a research collaboration with Japans National Cancer Center Hospital East

Takeda and Biological E. Limited Collaborate to Expedite Dengue Vaccine Availability in Endemic Areas

Tuesday, February 27, 2024

Takeda and Biological E Limited an Indian pharmaceutical company have recently joined forces in a strategic partnership to expedite access to QDENGA Dengue Tetravalent Vaccine

Everest Medicines and Kezar Life Sciences Obtain IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

Tuesday, February 27, 2024

Today Everest Medicines and Kezar Life Sciences Inc announced that the Center for Drug Evaluation of Chinas National Medical Products Administration has approved Kezars investigational new drug

Teva and Jiangsu Nhwa Establish Strategic Collaboration to Enhance Patient Access to AUSTEDO® in China

Monday, February 26, 2024

Teva Pharmaceutical Investments Singapore Pte Ltd a subsidiary of Teva Pharmaceutical Industries Ltd has partnered with Jiangsu Nhwa Pharmaceutical Co Ltd

CSL Vifor and Travere Therapeutics Announce That Sparsentan Has Obtained a Positive CHMP Opinion for the Treatment of IgA Nephropathy

Saturday, February 24, 2024

CSL Vifor and Travere Therapeutics Inc jointly announced today that the European Medicines Agencys Committee for Medicinal Products for Human Use has recommended the approval of sparsentan

Rhythm Pharmaceuticals Reveals Clinical Development Strategy for Setmelanotide in Addressing Hypothalamic Obesity in Japan

Friday, February 23, 2024

Rhythm Pharmaceuticals Inc a global commercialstage biopharmaceutical company specializing in rare neuroendocrine diseases has announced plans to expand its ongoing global Phase clinical trial

Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®

Friday, February 23, 2024

Ligand Pharmaceuticals Incorporated has announced that Eisai Co Ltd its partner has received approval for the injection formulation of their antiepileptic drug Fycompa

WuXi Advanced Therapies Receives FDA Approval for Manufacturing Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

Thursday, February 22, 2024

WuXi Advanced Therapies a subsidiary of WuXi AppTec has received approval from the US Food and Drug Administration to initiate analytical testing and manufacturing of AMTAGVI for Iovance

Dyadic Strengthens Collaboration with Israel Institute for Biological Research (IIBR) to Address Bio-Threats and Emerging Disease Solutions

Thursday, February 22, 2024

Dyadic International Inc a prominent biotechnology firm specializing in advanced microbial platforms for protein development and bioproduction has announced a significant advancement

Mabwell's Innovative B7-H3 ADC 7MW3711 Receives FDA IND Approval

Wednesday, February 21, 2024

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain recently announced the approval of its clinical trial application by the US Food and Drug Administration for BH targeting ADC designed for advanced malignant solid t...